The Tät-m app has been launched in collaboration with the Swedish Prostate Cancer Federation
The name of the app has been changed from TätIII to Tät-m and it has a new logo, a new
Read MoreArchives
Clinically relevant improvement depends on baseline severity
In a recently published study, we analysed how large reduction on the symptom score ICIQ –UI SF was required for a
Read MoreTreatment results at 15 weeks are important for long-term satisfaction
At the long-term follow-up after 15 months, 58% of the women were satisfied with treatment of mixed and urgency urinary
Read MoreThe Tät® III app in a new updated version
We have previously demonstrated that this app facilitates training for men undergoing radical prostatectomy. More than 10 000 men have used
Read MoreA brand new version of the Tät® app is now available from App Store
The pink app, which is now being produced by eContinence AB, contains simpler free content and the possibility to upgrade
Read MoreApp treatment among pregnant and postnatal women
Many pregnant and postnatal women used the freely available app Tät®, both for prevention and treatment of urinary incontinence. 3680
Read MoreTät® app – new and improved
The research behind our first app – the Tät® app – is now complete, and that means that the app
Read MoreThe Tät® III app facilitates pelvic floor muscle training with start before surgery for prostate cancer
Of the men who trained with the app for three months, 97% felt that it facilitated their training, and the
Read MoreHealth economic analysis of the app Tät®II
A health economic analysis of the app Tät®II for treatment of mixed and urge urinary incontinence was recently published in
Read MoreApp treatment for urgency-related incontinence had a good long-term effect
We have investigated the long-term results of treatment with the app Tät®II for urgency and mixed incontinence in women. The
Read More